These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Treatment of Staphylococcus aureus prosthetic valve endocarditis. Hassoun A Am J Med; 2007 Mar; 120(3):e9; author reply e11. PubMed ID: 17349434 [No Abstract] [Full Text] [Related]
27. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics. Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041 [TBL] [Abstract][Full Text] [Related]
28. Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis. Gomez EO; Jafary A; Dever LL Microb Drug Resist; 2010 Sep; 16(3):241-4. PubMed ID: 20617926 [TBL] [Abstract][Full Text] [Related]
29. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Heldman AW; Hartert TV; Ray SC; Daoud EG; Kowalski TE; Pompili VJ; Sisson SD; Tidmore WC; vom Eigen KA; Goodman SN; Lietman PS; Petty BG; Flexner C Am J Med; 1996 Jul; 101(1):68-76. PubMed ID: 8686718 [TBL] [Abstract][Full Text] [Related]
30. The effect of slime production on vancomycin efficacy in the treatment of experimental endocarditis due to Staphylococcus epidermidis. Baddour LM; Christensen GD; Schadow KH J Antimicrob Chemother; 1989 Sep; 24(3):365-73. PubMed ID: 2808192 [TBL] [Abstract][Full Text] [Related]
33. Staphylococcus capitis endocarditis: two cases and review of the literature. Sandoe JA; Kerr KG; Reynolds GW; Jain S Heart; 1999 Sep; 82(3):e1. PubMed ID: 10455099 [TBL] [Abstract][Full Text] [Related]
34. The use of rifampicin in staphylococcal infections--a review. Kapusnik JE; Parenti F; Sande MA J Antimicrob Chemother; 1984 Jun; 13 Suppl C():61-6. PubMed ID: 6381463 [No Abstract] [Full Text] [Related]
35. Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis. Prabhudesai S; Kanjani A; Nambi PS; Gnanasambandam S; Ramachandran B Pediatr Infect Dis J; 2016 May; 35(5):517-8. PubMed ID: 27074655 [TBL] [Abstract][Full Text] [Related]
36. Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis. Tebas P; Martinez Ruiz R; Roman F; Mendaza P; Rodriguez Diaz JC; Daza R; de Letona JM J Infect Dis; 1991 Jan; 163(1):204-5. PubMed ID: 1984473 [No Abstract] [Full Text] [Related]
37. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Small PM; Chambers HF Antimicrob Agents Chemother; 1990 Jun; 34(6):1227-31. PubMed ID: 2393284 [TBL] [Abstract][Full Text] [Related]
38. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. Gopal V; Bisno AL; Silverblatt FJ JAMA; 1976 Oct; 236(14):1604-6. PubMed ID: 989135 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. Sande MA; Johnson ML J Infect Dis; 1975 Apr; 131(4):367-75. PubMed ID: 1117194 [TBL] [Abstract][Full Text] [Related]
40. Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis. Kaatz GW; Seo SM; Barriere SL; Albrecht LM; Rybak MJ Antimicrob Agents Chemother; 1989 Aug; 33(8):1184-7. PubMed ID: 2802547 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]